These consortia will focus on biological systems research in the areas of animal and human models, plants, and microbiology. When fully implemented, the awards for these consortia will total about $5 ...

“Moderna obtained technical know-how relating to GSK biologicals’s mRNA vaccine platform technology by hiring several former Novartis and GSK employees with first-hand knowledge of the Mandl team’s ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...

According to GSK, as much as 4% of the general population is affected by the condition, which can be associated with asthma and allergic rhinitis. Dupixent, which has become one of the pharmaceutical ...